IRTC Stock Analysis: Buy, Sell, or Hold?

IRTC - iRhythm Technologies, Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$113.11
2.99 (2.72%) ▲
5d: +3.92%
30d: -2.96%
90d: -4.7%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Jul 30, 2026

Get Alerted When IRTC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IRTC trading at deep discount. Market pricing in -7.3% annual earnings decline, creating value opportunity for patient investors.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$51.18
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$31.78
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: IRTC is currently trading at $113.11, which is considered slightly high relative to its 30-day fair value range of $106.63 to $115.26. From a valuation perspective, the stock is trading at a discount (Forward PE: 104.8) compared to its historical average (131.5). Remarkably, the market is currently pricing in an annual earnings decline of 7.3% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, IRTC is in a strong downtrend. Immediate support is located at $100.85, while resistance sits at $118.08.

Market Sentiment: IRTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $178.93 (+62.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $106.63 - $115.26
Company Quality Score 60/100 (BUY)
Volume Confirmation HIGH
Confidence Score 80.8%

All Signals

  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 62.5% below Wall St target ($178.93)

Trading Range Analysis

30-Day Trading Range $106.63 - $115.26
Current vs Trading Range SLIGHTLY HIGH
Expected Move (7 Days) ±$8.02 (7.1%)

Support & Resistance Levels

Support Level $100.85
Resistance Level $118.08
Current Trend Strong Downtrend
Technical data as of Jun 24, 2026

Fundamental Context

Forward P/E (Next Year Est.) 104.75
Wall Street Target $178.93 (+62.5%)
Revenue Growth (YoY) 25.7%
Profit Margin -3.5%
Valuation Discount vs History -7.3% cheaper
PE vs Historical 104.8 vs 131.5 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -7.3% (market-implied from PE analysis)
1-Year Target $102.08 (-7%)
2-Year Target $94.63 (-14%)
3-Year Target $87.72 (-20%)
3-Yr Target (if PE normalizes) (PE: 105→132) $110.13 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 104.7, Growth: 800.1%) $371.66 (+238%)
Base: (SPY PE: 21.8, Growth: 800.1%) $77.28 (-30%)
Bear: (PE: 18.5, Growth: 800.1%) $65.69 (-40%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 104.7 to 131.5
Stabilization Target: $138.25 (+25.5%)
PE Expansion Potential: +25.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 3:30 PM ET
Data refreshes hourly during market hours. Next update: 4:30 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Marc Wade Rosenbaum SELL 816 shares 2026-03-02
Chad Patterson SELL 4444 shares 2026-03-02
Sumi Shrishrimal SELL 2830 shares 2026-03-02

Unlock Insider Activity

See real-time buying/selling by company executives for IRTC.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SYK
Stryker Corporation
BUY
32 analysts
$387 67 BUY
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$117 65 BUY
MDT
Medtronic PLC
BUY
32 analysts
$98 61 BUY
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$97 59 HOLD
ZBH
Zimmer Biomet Holdings I…
HOLD
29 analysts
$99 60 HOLD

Advanced IRTC Option Strategies

Professional options setups generated by AI based on today's IRTC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for IRTC

IRTC Technical Chart IRTC Price Prediction IRTC Earnings Date IRTC Investment Advisor IRTC Fair Price Analyzer IRTC Options Advisor IRTC Options Chain IRTC Options Analysis IRTC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals